Home Ingredients Iron Polysaccharide Complex (Niferex®)
Bone HealthImmune Support

Iron Polysaccharide Complex (Niferex®)

Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Iron polysaccharide complex (brands: Niferex®, Nu-Iron®) is ferric iron (Fe³⁺) bound to a polysaccharide carrier — designed for delayed iron release in the small intestine to minimize gastric irritation. Marketed for better tolerability than ferrous sulfate. Critical evidence: head-to-head trial showed iron polysaccharide complex significantly less effective than ferrous sulfate for raising hemoglobin (2.84 vs 0.60 g/dL change at 12 weeks). Tolerability advantage exists but at substantial cost to therapeutic effectiveness.

Studied Dose 150-300 mg elemental iron/day (Niferex® Forte = 150 mg elemental iron per capsule)
Active Compound Iron polysaccharide complex (ferric iron + polysaccharide carrier)

Benefits

Better GI Tolerability

Iron polysaccharide complex causes substantially fewer GI side effects than ferrous sulfate — less constipation, less nausea, less abdominal cramping. Designed for delayed release in small intestine reduces gastric irritation.

Supported by Trial 2, Trial 1

Higher Elemental Iron Per Capsule

Niferex® Forte contains 150 mg elemental iron per capsule — among the highest single-dose iron content. Reduces pill burden vs multiple ferrous sulfate or gluconate tablets.

Supported by Trial 1, Trial 2

No Stomach Acid Required (Unlike Carbonate)

Iron polysaccharide complex is dispersed in polysaccharide matrix — does not require gastric acid for dissolution. Theoretically advantageous for PPI users.

Supported by Trial 1, Trial 2

Pediatric Liquid Forms Available

Iron polysaccharide complex liquid (Nu-Iron® Pediatric) is available for pediatric iron supplementation when liquid forms preferred. Better tolerability than ferrous sulfate elixir.

Supported by Trial 1, Trial 2

Marketing-Driven Popularity

Despite lower effectiveness, iron polysaccharide complex is frequently prescribed/recommended by clinicians who prioritize tolerability over hemoglobin response. Important to understand the trade-off.

Supported by Trial 1, Trial 2

Mechanism of action

1

Ferric (Fe³⁺) Form Requires Reduction

Iron polysaccharide complex provides ferric iron (Fe³⁺) — must be reduced to ferrous (Fe²⁺) before absorption via DMT1. This reduction step is rate-limiting and often inefficient — major reason for poor bioavailability vs ferrous salts (which provide directly-absorbable Fe²⁺).

2

Delayed Polysaccharide Release

Iron is bound within polysaccharide matrix that gradually disperses in small intestine — slower iron release vs ferrous salts. Reduces gastric mucosal irritation but also reduces concentration available for absorption.

3

Lower Bioavailability (Liu 2008)

Liu 2008 head-to-head RCT in IDA patients: ferrous sulfate raised hemoglobin 2.84 g/dL vs iron polysaccharide complex 0.60 g/dL at 12 weeks (P<0.0001). Niferex group also had less ferritin and MCV improvement. Major effectiveness gap despite equal elemental iron dosing.

4

Standard Iron Functions Once Absorbed

Once iron is absorbed (less efficiently than from ferrous salts), it functions normally in hemoglobin synthesis, etc.

Clinical trials

1
Iron Polysaccharide Complex vs Ferrous Sulfate — Liu 2008 negative for IDA

Open-label clinical trial comparing equivalent daily doses of iron polysaccharide complex (150 mg elemental iron) vs ferrous sulfate (150 mg elemental iron) for 12 weeks in IDA patients. (Liu et al. 2008)

IDA patients.

Ferrous sulfate group — hemoglobin increase 2.84 g/dL; iron polysaccharide complex group — hemoglobin increase only 0.60 g/dL (P<0.0001). Substantial bioavailability/effectiveness gap. Polysaccharide complex group also had less ferritin, less MCV improvement. Polysaccharide complex's tolerability advantage came at substantial cost to therapeutic effectiveness.

2
Iron Polysaccharide Complex Tolerability — Surveys

Tolerability comparisons of iron polysaccharide complex vs ferrous sulfate in clinical practice.

Iron-supplementing patients.

Iron polysaccharide complex consistently reports fewer GI side effects than ferrous sulfate. Patients prefer; adherence higher. But effectiveness lower (Liu 2008).

Side effects and drug interactions

Common Potential side effects

Generally fewer GI side effects than ferrous sulfate.
Mild nausea, constipation possible but less common.
Dark/normal stools (less staining than ferrous salts).
Headache rare.
Reduced effectiveness for IDA treatment (Liu 2008) — major clinical limitation.
Pediatric iron poisoning — same caution as all iron forms; child-resistant packaging mandatory.

Important Drug interactions

Same general iron drug interactions: tetracyclines, quinolones, levothyroxine, bisphosphonates, levodopa — separate by 2-4 hours.
Calcium — competes for absorption.
Coffee/tea — reduces absorption.
Vitamin C — enhances absorption (more important with ferric form which requires reduction).
PPIs/antacids — less impact on iron polysaccharide than on ferrous sulfate (theoretical advantage).

Featured in these supplement guides

Restless Legs Syndrome→

More Bone Health Ingredients

Bone Health
Calcium
Calcium is the most abundant mineral in the body — about 99% stored in bones and teeth, wi…
Bone Health
Vitamin D
Vitamin D is a fat-soluble vitamin and steroid hormone precursor essential for calcium abs…
Bone Health
Copper
Copper is an essential trace mineral and cofactor for over 30 enzymatic reactions, includi…
Bone Health
Ferrous Sulfate
Ferrous sulfate is the most common, cheapest, and longest-established oral iron form — rec…

Frequently asked questions about Iron Polysaccharide Complex (Niferex®)

What is Iron Polysaccharide Complex?

Iron polysaccharide complex (brands: Niferex®, Nu-Iron®) is ferric iron (Fe³⁺) bound to a polysaccharide carrier — designed for delayed iron release in the small intestine to minimize gastric irritation. Marketed for better tolerability than ferrous sulfate.

What is Iron Polysaccharide Complex used for?

Iron Polysaccharide Complex is researched primarily for Bone Health and Immune Support. Iron polysaccharide complex causes substantially fewer GI side effects than ferrous sulfate — less constipation, less nausea, less abdominal cramping. Designed for delayed release in small intestine reduces gastric irritation.

What is the recommended dosage of Iron Polysaccharide Complex?

The clinically studied dose is 150-300 mg elemental iron/day (Niferex® Forte = 150 mg elemental iron per capsule) Always follow the product label and check with a healthcare provider for personal advice.

Is Iron Polysaccharide Complex safe, and does it have side effects?

For most healthy adults, Iron Polysaccharide Complex is well tolerated at studied doses. Reported effects can include: Generally fewer GI side effects than ferrous sulfate. Mild nausea, constipation possible but less common. It may also interact with some medications. Iron Polysaccharide Complex is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Iron Polysaccharide Complex interact with any medications?

Possible interactions include: Same general iron drug interactions: tetracyclines, quinolones, levothyroxine, bisphosphonates, levodopa — separate by 2-4 hours. Calcium — competes for absorption. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Iron Polysaccharide Complex?

NutraSmarts rates the evidence for Iron Polysaccharide Complex as Limited (2 out of 5). It is backed by 2 clinical trials and 2 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(2 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Liu TC, Lin SF, Chang CS, Yang WC, Chen TP Comparison of a combination ferrous fumarate product and a polysaccharide iron complex as oral treatments of iron deficiency anemia: a Taiwanese study International Journal of Hematology. 2004;80(5):416-20. doi: 10.1532/ijh97.a10409.PubMedUsed to support: Head-to-head comparison study of polysaccharide iron complex vs. ferrous fumarate in patients with iron deficiency anemia; directly backs 'Better GI Tolerability' and 'Marketing-Driven Popularity' with evidence on clinical equivalence and tolerability.
  2. Zhang YY, Liu JH, Su F, Lui YT, Li JF Single-dose bioequivalence assessment of two formulations of polysaccharide iron complex capsules in healthy adult male Chinese volunteers: A sequence-randomized, double-blind, two-way crossover study Current Therapeutic Research, Clinical and Experimental. 2009;70(2):104-15. doi: 10.1016/j.curtheres.2009.04.006.PubMedUsed to support: Randomized bioequivalence study of polysaccharide iron complex formulations characterizing pharmacokinetics and absorption; backs 'Higher Elemental Iron Per Capsule' and 'No Stomach Acid Required' as formulation-level properties of polysaccharide iron complex.